References
- GLENN, M.: Nerve block. In: M. Glenn and J. Whyte (editors) The Practical Management of Spasticity in Children and Adults (London: Lea and Febiger), pp. 227–259, 1990.
- BRAUN, R., HOPPER, M., MOONEY, V. et al.: Phenol nerve block in the treatment of acquired spastic hemiplegia in the upper limb. The Journal of Bone and Joint Surgery, 55-A: 580–585, 1973.
- SHEEAN, G.: The management of spasticity with botulinum toxin. European Journal of Neurology, 4 (suppl 2): S41—S45, 1997.
- DAS, T. and PARK, D.: Effect of treatment with Botulinum toxin on spasticity. Postgraduate Medical Journal, 65: 208–210, 1989.
- SNOW, B., Tsui, J., BHATT, M. et al.: Treatment of spasticity with Botulinum toxin: a double-blind study. Annals of Neurology, 28: 512–515, 1990.
- YOSHIMURA, D., ADMINOFF, M. and OLNEY, R.: Botulinum toxin therapy for limb dystonias. Neurology, 42: 627–630, 1992.
- HESSE, S., LUECICE, D., MALEZIC, M. et al.: Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. Journal of Neurology, Neurosurgery and Psychiatry, 57: 1321–1324, 1994.
- DUNNE, J., HEYE, N. and DUNNE, S.: Treatment of chronic limb spasticity with Botulinum toxin A. Journal of Neurology, Neurosurgery and Psychiatry, 58: 232–235, 1995.
- HESSE, S., KRAJNIK, J., LUECICE, D. et al.: Ankle muscle activity before & after Botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke, 27: 455–460, 1996.
- BuRBAun, P., WIART, L., Dumps, J. et al.: A randomised, double blind, placebo controlled trial of Botulinum toxin in the treatment of spastic foot in hemiparetic patients. Journal of Neurology, Neurosurgery and Psychiatry, 61: 265–269, 1996.
- WILSON, D., CHILDERS, M., COOICE, D. et al.: Kinematic changes following Botulinum toxin injection after traumatic brain injury. Brain Injury, 11: 157–167, 1997.
- WILSON, D., ClinnERs, M., SMITH, B. et al.: Ground reaction force changes in hemiparetic gait following Botulinum toxin injection. Journal of Neurological Rehabilitation, 11: 81–89, 1997.
- SIMPSON, D. M., ALEXANDER, D. N., O'BRIEN, C. F. et al.: Botulinum toxin type A in the treatment of upper extremity spasticity: a randomised, double-blind, placebo controlled trial. Neurology, 46: 1306–1310, 1996.
- YABLON, S. A., AGANA, B. T., IVANHOE, C. B. et al.: Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open labelled trial. Neurology, 47: 939–944, 1996.
- PIERSON, S., KATZ, D. and TARSY, D.: Botulinum toxin A in the treatment of spasticity: functional implications & patient selection. Archives of Physical Medicine & Rehabilitation, 77: 717–721, 1996.
- REITER, F., DANNI, M., LAGALLA, G. et al.: Low dose Botulinum toxin with ankle taping for treatment of spastic equinovarus foot after stroke. Archives of Physical Medicine & Rehabilitation, 79: 532–535, 1998.
- AMERICAN ACADEMY OF ORTHOPAEDIC SuRGEoNs: Joint Motion—Method of Measuring and Recording (Edinburgh: Churchill), pp. 68–69, 1965.
- BOHANNON, R. and SMITH, M.: Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy, 67: 206–207, 1987.
- WINTER, D.: Foot trajectory in human gait: a precise and multifactorial motor control task. Physical Therapy, 72: 45–53, 1992.
- RADENSKY, P. W., ARCHER, J. W., DOURNAUX, S. F. et al.: The estimated cost of managing focal spasticity: a physician practice patterns survey. Neurorehabilitation and Neural Repair, 15: 57–68, 2001.
- WALLESCH, C.-W., Ms, E., LECOMTE, P. et al.: Cost effectiveness of botulinum toxin type A in patients with spascticity following stroke: a German perspective. European Journal of Neurology, 4 (Suppl 2): S53–557, 1997.